Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Copenhagen University Hospital at Herlev
NCT06632444 · Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT06287723 · Colorectal Cancer, Liver Metastases, and more
NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
Copenhagen Uni. Hospital at Herlev dept. of Radiology
Herlev
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions